Novo Nordisk alleges Singaporean biotech KBP Biosciences made misleading statements before the two firms inked a licensing ...
Malay Mail on MSN1d
Singapore biotech tycoon Huang Zhenhua’s assets frozen over US$830m suit after misleading Novo Nordisk on ‘new and effective’ hypertension drug, court rulesDanish pharmaceutical giant Novo Nordisk has secured a court order to freeze the worldwide assets of Singapore-based KBP Biosciences and its founder Huang Zhenhua, amid a legal battle over an ...
Novo Nordisk is seeking up to US$830 million in damages from KBP Biosciences, according to a ruling by a Singapore court, as ...
Novo Nordisk, the Danish pharmaceutical giant, has filed a lawsuit against Singapore-based KBP Biosciences and its founder, ...
Wegovy maker Novo Nordisk is accusing Mr Huang and his firm of fraudulent claims over a hypertension drug. Read more at ...
Novo Nordisk is seeking up to US$830 million (S$1.1 billion) in damages from KBP Biosciences, according to a ruling by a Singapore court, as the Danish drugmaker says it was misled when it bought a ...
Pharmaceutical giant Novo Nordisk is seeking as much as US$830 million (S$1.1 billion) in damages in an application to a ...
MT Newswires on MSN2d
European Equities Close Lower in Wednesday Trading; UK Inflation Rises Higher Than ExpectedThe European stock markets closed lower in Wednesday trading as The Stoxx Europe 600 lost 0.95%, Germany's DAX dropped 1.79%, the FTSE 100 in London was down 0.69%, France's CAC 40 fell 1.27%, and the ...
Danish pharma major Novo Nordisk has sued KBP Biosciences and its founder and executive chairman, Huang Zhenhua, for $830 ...
PHARMA giant Novo Nordisk has been granted an injunction by the Singapore International Commercial Court to freeze the ...
PHARMA giant Novo Nordisk has been granted an injunction by the Singapore International Commercial Court to freeze the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback